Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:53 AM
Ignite Modification Date: 2025-12-26 @ 1:34 AM
NCT ID: NCT00737633
Description: None
Frequency Threshold: 4
Time Frame: AEs were collected from when written informed consent was provided through 28 days after the last dose of investigational product.
Study: NCT00737633
Study Brief: Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
16-week Population subjects who were randomized to placebo in previous study None None 1 44 33 44 View
72-week Population subjects who were randomized to active during previous study None None 0 57 34 57 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Coronary Artery Disease SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (10.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
dysgeusia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (10.0) View
abdominal distension SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
eye pain SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (10.0) View
upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (10.0) View
gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (10.0) View
sinusitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (10.0) View
nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (10.0) View
influenza SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (10.0) View
parasthesia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (10.0) View
dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (10.0) View
headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (10.0) View
nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
gastritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
dry mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
hypoglycemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (10.0) View
insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (10.0) View
anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (10.0) View
fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (10.0) View
irritability SYSTEMATIC_ASSESSMENT General disorders MedDRA (10.0) View
back injury SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (10.0) View
lacrimation increased SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (10.0) View
chromatopsia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (10.0) View
nasal congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (10.0) View